729595-79-3

Basic information

• Product Name: (2R,3R,4R,5R)-2-(4-amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate
• Synonyms: (2R,3R,4R,5R)-2-(4-amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate
• CAS NO: 729595-79-3
• Molecular Weight: 696.514
• Mol File: 729595-79-3.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: (2R,3R,4R,5R)-2-(4-amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: (2R,3R,4R,5R)-2-(4-amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate(729595-79-3)
• EPA Substance Registry System: (2R,3R,4R,5R)-2-(4-amino-6-bromo-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate(729595-79-3)

Safety Data

• Hazardous Substances Data: 729595-79-3(Hazardous Substances Data)

Upstream product

• 19393-83-0 4-amino-6-bromo-5-cyanopyrrolo[2,3-d]pyrimidine 
• 15397-15-6 1,2,3,5-tetra-O-benzoyl-2-C-methyl-β-D-ribofuranose 

Downstream Products

• 729595-88-4 C₄₀H₃₆N₆O₁₀ 
• 729595-85-1 C₃₈H₃₆N₆O₇ 
• 729595-86-2 C₃₆H₃₂N₆O₈ 
• 729595-84-0 C₃₇H₃₄N₆O₇ 
• 729595-87-3 C₃₇H₃₂N₆O₈ 
• 729595-83-9 C₃₆H₃₂N₆O₇ 
• 729595-82-8 C₃₅H₃₀N₆O₇ 
• 729595-80-6 C₃₄H₂₆N₄O₈ 
• 729595-81-7 C₃₄H₂₅ClN₄O₇ 
• 729595-78-2 (2R,3R,4R,5R)-2-(4-amino-5-cyano-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-5-(benzoyloxymethyl)-3-methyltetrahydrofuran-3,4-diyl dibenzoate 

Relevant articles and documents

SUBSTITUTED AMINE DERIVATIVE AND MEDICINAL COMPOSITION COMPRISING SAME AS THE ACTIVE INGREDIENT

A compound represented by following general formula (I) : wherein, ---- represents a single bond or a double bond; L represents -NH- or the like; X1 represents N or C, provided that in the case where X1 is N, X2 represents

Synthesis of new 2′-β-C-methyl related triciribine analogues as anti-HCV agents

Ten new β-D-ribofuranosyl and 2′-β-C-methyl- β-D-ribofuranosyl triciribine derivatives 4-13 with various N4 and 6-N substituents on the tricyclic ring were synthesized from the corresponding toyocamycin and new 2′-β-C-methyl toyocamy